The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
The Lentechs Apioc-S and Apioc-A contact lenses are made in an FDA-approved contact lens material indicated for single-vision and astigmatism. The novel lens design has a lenticular portion which is thicker than the optical portion of the lens. When applied to the eye, it is oriented in a superior position. Unlike contact lenses currently on the market, this innovative design improves lens stability by preventing lens rotation, and may improve tear flow behind the lens.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 35 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
The subject must provide written informed consent.
The subject must appear willing and able to adhere to the instructions set forth in this protocol.
At least 18 years of age and no more than 35 years of age.
≤ 4.00 D of corneal astigmatism.
≤ 4.00 D of refractive astigmatism.
Refractive error range +20.00 DS to -20.00 DS
Flat and steep keratometry readings within 40 to 50D.
Clear, healthy corneas with no irregular astigmatism.
Normal, healthy conjunctiva in both eyes.
Free of active ocular disease. Refractive error is permitted.
Be a current or former (within the last 12 months) contact lens wearer.
Best-corrected near and distance visual acuity better than or equal to 20/25.
Irregular corneal astigmatism.
Corneal scarring unless off line-of-site and well healed.
Pinguecula, pterygium, or other conjunctival thickness abnormalities that would interfere with soft contact lens wear.
Recent use of any ocular pharmaceutical treatments, including daily artificial tears, in the two weeks prior to the examination. Use of artificial tears less than 3 drops per week is permitted.
Systemic disease that would interfere with contact lens wear.
Currently pregnant or lactating (by self-report).
History of strabismus or eye movement disorder.
Active allergies that may inhibit contact lens wear.
Upper eyelid margin at or above the superior limbus.